Metraipolis › archive › dc_dbce3dbfbbb9

Engineering macrophages for cancer immunotherapy: emerging insights and therapeutic potential — Europe PMC PMID:42032323

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42032323
DOI: 10.1038/s44385-[numero omesso]-y
License (as archived): solo-consultazione
Archived: 2026-11-05T10:01:05.393Z
SHA-256 of the archived text: 3b8a0835ab3d207b0a1293fd9a9b4f7de201efc921d36e9171825c5deae15e54
Stable URL of this page: https://metraipolis.com/documento/dc_dbce3dbfbbb9

How to cite

Engineering macrophages for cancer immunotherapy: emerging insights and therapeutic potential — Europe PMC PMID:42032323 — Europe PMC (en), https://europepmc.org/article/MED/42032323 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dbce3dbfbbb9 (Metraipolis archive dc_dbce3dbfbbb9, sha256 3b8a0835ab3d207b0a1293fd9a9b4f7de201efc921d36e9171825c5deae15e54)

BibTeX

@misc{dcdbce3dbfbbb9,
  title = {Engineering macrophages for cancer immunotherapy: emerging insights and therapeutic potential — Europe PMC PMID:42032323},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42032323},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dbce3dbfbbb9; sha256 3b8a0835ab3d207b0a1293fd9a9b4f7de201efc921d36e9171825c5deae15e54},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42032323. Agents can read the archived copy with the MCP tool read_document.